You searched for Humanized antibody - Page 35 of 44

News and Trends 16 Feb 2021

Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze

…the original deal, CRUK would fund and conduct part of the clinical development of BioInvent’s lead antibody drug in exchange for milestone payments and royalties from the Swedish company. Under…

February 16, 2021 - 4 minutesmins - By Anita Chakraverty

In Depth 14 Apr 2023

mRNA vaccines: a promising future

…vaccine that applies a similar mechanism whereby host cells are instructed to make copies of spike proteins to induce an immune response for antibody production. The first COVID 19 vaccine…

April 14, 2023 - 7 minutesmins - By Roohi Mariam Peter

News and Trends 7 May 2019

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

…me. “Our technology uses antibody fragments that stabilize and push the GPCR into the active state while maintaining the natural sensitivity of the receptor.” Once the GPCR is locked…

May 7, 2019 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 30 Jan 2017

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

Ossianix, partnered with Lundbeck, is developing shark antibodies that can help therapeutics cross the blood brain barrier. Ossianix develops shark-inspired antibody fragments, VNARs, with outstanding properties thanks to their small…

January 30, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Best in Biotech 19 Sep 2024

Six immunology biotech companies revolutionizing immune treatments in 2024

…agonist antibody designed to regulate T-cell homeostasis by targeting PSGL-1. By binding PSGL-1, it could downregulate chronically activated T cells without altering the activity of resting and early-activated T cells,…

September 19, 2024 - 7 minutesmins - By Willow Shah-Neville

Best in Biotech 30 Dec 2024

Six biotech companies leading the way in India

…rapid identification of selective and potent monoclonal antibodies with the potential to enhance antibody-dependent cellular cytotoxicity (ADCC) activity. Zumutor’s lead candidate, ZM008, is a first-in-class monoclonal antibody that disrupts the…

December 30, 2024 - 8 minutesmins - By Willow Shah-Neville

News and Trends 20 Feb 2018

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

Phase I results show promise for a new treatment for atopic dermatitis that may become a strong competitor to the market leader, Humira. Morphosys and Galapagos are developing an antibody…

February 20, 2018 - 3 minutesmins - By Alexander Burik

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

…money to fund the preclinical development of antibody drugs for unspecified autoimmune diseases. The company will also expand its drug discovery efforts to other unspecified disease areas and grow its…

October 7, 2019 - 2 minutesmins - By Jonathan Smith

News and Trends 9 Aug 2022

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

…issued two patents that will protect Arecor Therapeutics’ formulations of high-concentration adalimumab until 2038. The company made the announcement today (August 9). Monoclonal antibody Adalimumab, sold by AbbVie under the…

August 9, 2022 - 3 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…(BDCs) outperform ADCs? Bicycle Therapeutics is a company in Cambridge founded by one of the top biotech leaders in the UK’s golden triangle. Its unique technology to develop antibody-like bicyclic…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 14 Jul 2022

Boston startup bags $40M Series A to smash preclinical bottlenecks

…of the startup is a type of drugs called targeted effectors. This class, including cell engagers and antibody-drug conjugates, involves attaching a therapeutic payload onto a carrier molecule that delivers…

July 14, 2022 - 3 minutesmins - By Jonathan Smith

News and Trends 14 Mar 2023

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

…next generation of cancer breakthroughs and bring new solutions to patients by combining the power of Seagen’s antibody-drug conjugate (ADC) technology with the scale and strength of Pfizer’s capabilities and…

March 14, 2023 - 6 minutesmins - By Jim Cornall

Knowledge hub

Categories

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Approaches

Therapeutic areas

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Humanized antibody

Cancer Research UK Cuts Two Biotech Collaborations Amid Pandemic Squeeze

mRNA vaccines: a promising future

Belgian Biotech Raises €30M Series A to Unlock Undruggable Targets

‘Trojan Horse’ Shark Antibodies could beat the Blood Brain Barrier

Six immunology biotech companies revolutionizing immune treatments in 2024

Six biotech companies leading the way in India

Morphosys and Galapagos Announce Positive Phase I Results for Atopic Dermatitis Treatment

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Formulations of Arecor Therapeutics’ drug to treat inflammatory diseases granted patents

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

Boston startup bags $40M Series A to smash preclinical bottlenecks

Pfizer’s $43B Seagen acquisition doubles early-stage oncology clinical pipeline

Subscribe to our newsletter to get the latest biotech news!

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

10 oncology deals in 2025 spotlight where industry leaders are betting big

10 biotech companies leading the way in Denmark

Webinar: Advancements in antimalarial drug discovery and development

Six psychedelic drug companies aiming to revolutionize mental health treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!